Literatur
Bayr G (1989) Hahnemanns Selbstversuch mit der Chinarinde im Jahre 1790. Haug, Heidelberg
Barthel P (1998) Hahnemanns Vermächtnis, der Chinarindenversuch. Z Klass Homoopath 42:29
Möllinger H, Schneider R, Walach H (2009) Homeopathic pathogenetic trials produce symptoms different from placebo. Forsch Komplementarmed 16:105–110
Walach H, Möllinger H, Sherr J, Schneider R (2008) Homeopathic pathogenetic trials produce more specific than non-specific symptoms: results from two double-blind placebo controlled trials. J Psychopharmacol 22:543–552
Walach H, Teut M (2015) Scientific provings of ultra high dilutions in humans. Homeopathy 104:322–327
Vonessen F (1980) Was krank macht, ist auch heilsam. Mythisches Gleichheitsdenken, Aristoteles’ Katharsis Lehre und die Idee der homöopathischen Heilkunst. Haug, Heidelberg
Carlucci MJ, Damonte EB, Scolaro LA (2011) Virus driven evolution: a probable explanation for “Similia similus curantur” philosophy. Infect Genet Evol 11:798–802
Teixeira MZ (1999) Similitude in modern pharmacology. Br Homeopath J 88:112–120
Schott EU (1990) Homöopathie und personzentrierte Psychotherapie: Ihre Gemeinsamkeiten, ihr Zusammenspiel – dargestellt and einem klinischen Fall. GwG Z 78:36–41
Eskinazi D (1999) Homeopathy re-revisited. Is homeopathy compatible with biomedical observations? Arch Intern Med 159:1981–1987
Bell IR, Kothan M (2012) A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization n a complex adaptive system. BMC Complement Altern Med 12:191
Bell IR, Ives JA, Wayne BJ (2014) Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions. Dose Response 12(2):202–232
Walach H (2003) Entanglement model of homeopathy as an example of generalized entanglement predicted by Weak Quantum Theory. Forsch Komplementarmed Klass Naturheilkd 10:192–200
Kuhn T (1962) The structure of scientific revolutions. University of Chicago Press, Chicago
Laudan L (1981) Science and hypothesis. Reidel, Dordrecht
Laudan L (1977) Progress and its problems: towards a theory of scientific growth. University of California Press, Berkeley
Suppe F (Hrsg) (1977) The structure of scientific theories. University of Illinois Press, Urbana
Walach H, Fischer K (2014) Leserbrief zu Christian Weymayr: „Scientabilität – ein Konzept zum Umgang der EbM mit homöopathischen Arzneimitteln“. Z. Evid. Fortbild. Qual. Gesundh.wesen (ZEFQ) (2013) 107, 606–610. Z Evid Fortbild Qual Gesundhwes 108(80):e81–e83
Doesburg P, Andersen JO, Scherr C, Baumgartner S (2019) Empirical investigation of preparations produced according to the European Pharmacopoeia monograph 1038. Eur J Pharm Sci 137:104987
Endler PC, Bellavite P, Bonamin L, Jäger T, Mazon S (2015) Replications of fundamental research models in ultra high dilutions 1994 and 2015—update on a bibliometric study. Homeopathy 104:234–245
Horton R (2015) Offline: What is medicine’s 5 sigma? Lancet 385:1380
Ioannidis JPA (2005) Why most published research findings are false. PLoS Med 2:e124
Open Science Collaboration (2015) Estimating the reproducibility of psychological science. Science 349(6251):aac4716
Hahn RG (2013) Homeopathy: meta-analyses of pooled clinical data. Forsch Komplementarmed 20:376–381
Shang A, Huwiler-Münteler K, Nartey L, Jüni P, Dörig S, Sterne JAC, Pewsner D, Egger M (2005) Are the clinical effects of homeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 366:726–732
Lüdtke R, Rutten ALB (2008) The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. J Clin Epidemiol 61:1197–1204
Mathie RT, Lloyd SM, Legg LA, Clausen J, Moss S, Davidson JR, Ford I (2014) Randomised placebo-controlled trials of individualised homoeopathic treatment: sytematic review and meta-analysis. Syst Rev 3:142
National Health and Medical Research Council (2019) International center for allied health evidence: the effectiveness of homeopathy: an overview review of secondary evidence—an annotated draft report. National Health and Medical Research Council, Canberra (orig. 2012)
Haute Autorité de Santé (2019) Commission de la Transparence: Évaluation des médicament homéopathiques soumis à la procédure d’enregistrement prévue à l’articcle L.5121–13 du CSP. HAS, Paris
Walach H (2019) Frankreich hat die Homöopathie aus der Erstattung genommen. Wissenschaftliche Gesellschaft für Homöopathie, Köthen. https://www.homöopathie-forschung.info/frankreich/. Zugegriffen: 02.04.2020
Walach H (2006) The Swiss program for the evaluation of complementary medicine (PEK). J Altern Complement Med 12:231–232
Walach H, Linde K, Eichenberger R, Stalder H, Børlum Kristensen F, Kleijnen J (2006) Swiss Complementary Medicine Evaluation Programme: Summary consensus statement of the Review Board of the Swiss Complementary Medicine Evaluation Programme (Programm Evaluation Komplementärmedizin, PEK) regarding the PEK process and products. Homeopathy 95:28–30
Bornhöft G, Matthiessen PF (Hrsg) (2012) Homeopathy in healthcare: effectiveness, appropriateness, safety, costs. Springer, Heidelberg
Hróbjartsson A, Gøtzsche PC (2001) Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344:1594–1602
Howick J, Friedemann C, Tsakok M, Watson R, Tsakok T, Thomas J, Perera R, Fleming S, Heneghan C (2013) Are treatments more effective than placebos? A systematic review and meta-analysis. PLoS One 8:e62599
Vase L, Riley JL, Price DD (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99:443–452
Walach H (2001) Das Wirksamkeitsparadox in der Komplementärmedizin. Forsch Komplementarmed Klass Naturheilkd 8:193–195
Meissner K, Fässler M, Kleijnen J, Hróbjartsson A, Schneider A, Antes G, Linde K (2013) Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med 173:1941–1951
Walach H, Falkenberg T, Fonnebo V, Lewith G, Jonas W (2006) Circular instead of hierarchical—methodological principles for the evaluation of complex interventions. BMC Med Res Methodol 6:29
Walach H, Loef M (2015) Using a matrix-analytical approach to synthesizing evidence solved incompatibility problem in the hierarchy of evidence. J Clin Epidemiol 68:1251–1260
Walach H (2017) Der Minderwertigkeitskomplex der Psychotherapie oder die Frage nach dem Placebo: Einige Gedanken zur derzeitigen Diskussion. Verhaltenstherapie 27:53–56
Schwanitz HJ (1983) Homöopathie und Brownianismus 1795–1844. Fischer, Stuttgart, New York
Glaeske G, Ludwig W‑D, Weißbach L (2017) AMNOG: Pflicht zur späten Nutzenbewertung. Dtsch Arztebl Int 114:A 2086–A 2092
Hawke K, van Driel ML, Buffington BJ, McGuire TM, King D (2017) Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (review). Cochrane Database Syst Rev 9:CD5974
Friese K‑H, Kruse S, Lüdtke R, Moeller H (1997) The homoeopathic treatment of otitis media in children: comparisons with conventional therapy. Int J Clin Pharmacol Ther 35:296–301
Wustrow TP, Otovowen Study Group (2004) Alternative versus conventional treatment strategy in uncomplicated acute otitis media in children: a prospective, open, controlled parallel-group comparison. Int J Clin Pharmacol Ther 42:110–119
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Walach gibt an, dass ein kleiner Teil seines Einkommens aus der Publikationstätigkeit zum Thema Homöopathie stammt.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Dieser Artikel ist ein Kommentar zum Bundesgesundheitsblatt Artikel: N. Schmacke (2020) Homöopathie: Heilslehre „ohne Substanz“. Bundesgesundheitsbl. https://doi.org/10.1007/s00103-020-03125-8.
Rights and permissions
About this article
Cite this article
Walach, H. Kommentar zum Beitrag von Norbert Schmacke: Homöopathie: Heilslehre „ohne Substanz“. Bundesgesundheitsbl 63, 548–552 (2020). https://doi.org/10.1007/s00103-020-03136-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-020-03136-5